MA15.10 Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

S. Zhao; T. Jiang; X. Li; C. Zhao; C. Su; S. Ren; C. Zhou

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >MA15.10 Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

【24h】

MA15.10 Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

机译：MA15.10 T790M突变的丧失与中国高级NSCLC患者的早期进展相关，患者患有EGFR T790M

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共1页
作者
S. Zhao; T. Jiang; X. Li; C. Zhao; C. Su; S. Ren; C. Zhou;
展开▼
作者单位

Department of Medical Oncology Shanghai Pulmonary Hospital Thoracic Cancer Institute Tongji;

Department of Medical Oncology Shanghai Pulmonary Hospital Thoracic Cancer Institute Tongji;

Department of Lung Cancer and Immunology Shanghai Pulmonary Hospital Thoracic Cancer Institute;

Department of Lung Cancer and Immunology Shanghai Pulmonary Hospital Thoracic Cancer Institute;

Department of Medical Oncology Shanghai Pulmonary Hospital Thoracic Cancer Institute Tongji;

Department of Medical Oncology Shanghai Pulmonary Hospital Thoracic Cancer Institute Tongji;

Department of Lung Cancer and Immunology Shanghai Pulmonary Hospital Thoracic Cancer Institute;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. MA15.10 Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M [J] . S. Zhao, T. Jiang, X. Li, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：MA15.10 T790M突变的丧失与中国高级NSCLC患者的早期进展相关，患者患有EGFR T790M
2. Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment [J] . Furuta Hiromi, Uemura Takehiro, Yoshida Tatsuya, Anticancer Research: International Journal of Cancer Research and Treatment . 2018,第9期

机译：在初始EGFR-TKI治疗失败后患有EGFR T790M突变的NSCLC患者Esimertinib的疗效和安全数据
3. Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib [J] . Hochmair Maximilian J., Buder Anna, Schwab Sophia, Targeted oncology . 2019,第1期

机译：基于液检查基于EGFR T790M突变介导的EGFR T790M突变介导的AFATINIB治疗患者患者的患者，以及随后对OSIMERTINIB的回应
4. Detection of EGFR T790M Mutation in Circulating Tumor DNA by Using a Novel Highly Sensitive PNA-Based Method [C] . Jin Kim, Ji-Youn Han, Geon Kook Lee, International Molecular Medicine Tri-Conference. . 2015

机译：用新型高敏感的基于PCNA的方法检测循环肿瘤DNA的EGFR T790M突变
5. Mutation profiling in colorectal cancer patients with microsatellite instability; High frequency of BRCA2 and EGFR somatic mutations [D] . Deihimi, Safoora. 2016

机译：具有微卫星不稳定性的大肠癌患者的突变谱； BRCA2和EGFR体细胞突变的频率高
6. Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC and Subsequent Response to Osimertinib [O] . Maximilian J. Hochmair, Anna Buder, Sophia Schwab, -1

机译：基于液体活检的EGFR T790M突变介导的晚期EGFR突变阳性NSCLC患者对阿法替尼治疗的耐药性以及随后对奥西替尼的反应的鉴定
7. Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment [O] . HIROMI FURUTA, TAKEHIRO UEMURA, TATSUYA YOSHIDA, 2018

机译：在初始EGFR-TKI治疗失败后患有EGFR T790M突变的NSCLC患者Esimertinib的疗效和安全数据

MA15.10 Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

著录项

相似文献

相关主题

期刊订阅